Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003721	s-sm(smith),vasta-aineet	— (—)	99	106	100.00%	Distribution not available
3003721	sm(smith),vasta-aineet(s-smab)	— (—)	85	89	100.00%	Distribution not available
3003721	s-sm-ab	— (—)	49	49	100.00%	Distribution not available
3003721	smab	— (—)	37	47	100.00%	Distribution not available
3003721	s-sm(smith),vasta-aineet	u/ml (u/ml)	12	13	0.00%
3003721	s-sm-ab	u/ml (u/ml)	8	8	0.00%
3003721	sm(smith),vasta-aineet(s-smab)	u/ml (u/ml)	6	7	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other systemic involvement of connective tissue (FG)

9.32

39.95

1.1

2.59

2.70

u/ml

—

Other systemic involvement of connective tissue

7.89

35.29

1.1

2.59

2.56

u/ml

—

Systemic connective tissue disorders

6.44

31.88

1.1

2.46

2.56

u/ml

—

Pain in joint

5.12

23.30

1.2

1.1

1.37

2.91

u/ml

—

Finngen Rheumatological endpoints

151

3.17

18.05

1.1

2.27

3.00

u/ml

0.21

Other specific joint derangements/joint disorders

126

3.39

16.44

1.2

1.0

1.37

3.68

u/ml

—

Diseases of oesophagus, stomach and duodenum

174

2.92

16.37

1.1

2.56

2.00

u/ml

—

Other dorsopathies, not elsewhere classified

153

2.77

13.71

1.1

1.26

3.51

u/ml

—

Dorsalgia

153

2.77

13.44

1.1

1.54

3.51

u/ml

—

Dorsopathies

153

2.66

12.48

1.1

1.44

3.51

u/ml

—

Anxiety disorders

203

2.54

11.67

1.1

1.56

3.07

u/ml

—

Soft tissue disorders

144

2.65

11.54

1.1

1.14

3.14

u/ml

—

Anxiety (asthma-related co-morbidities)

160

2.81

11.35

1.1

1.56

3.20

u/ml

—

Neurotic, stress-related and somatoform disorders

203

2.52

11.32

1.1

1.56

3.07

u/ml

—

All anxiety disorders

171

2.73

11.04

1.1

1.56

3.19

u/ml

—

Other joint disorders

130

2.68

10.64

1.2

1.0

1.86

3.59

u/ml

—

Arthropathies

130

2.65

10.61

1.2

1.0

1.90

3.59

u/ml

—

Reimbursement for rheumatic diseases

171

2.86

10.55

1.1

2.48

2.16

u/ml

—

Other intervertebral disc disorders

127

2.70

9.78

1.1

1.40

2.94

u/ml

—

Anxiety disorders, excluding more controls

166

2.47

9.30

1.2

1.1

1.37

3.20

u/ml

—

First line medication for Crohn's disease

189

2.20

8.45

1.1

2.80

2.38

u/ml

0.12

Pain (limb, back, neck, head abdominally)

2.94

8.27

1.2

1.1

1.23

2.91

u/ml

—

Polyarthropathies

101

2.78

8.03

1.1

1.0

1.46

2.86

u/ml

—

Episodal and paroxysmal disorders

181

2.14

7.68

1.1

2.29

2.68

u/ml

—

ILD medications

193

2.11

7.47

1.1

3.42

2.16

u/ml

—

Autoimmune diseases excluding thyroid diseases

178

2.15

7.31

1.1

2.94

2.17

u/ml

—

Codeine

163

2.17

6.96

1.0

1.1

1.14

3.05

u/ml

—

Pain in throat and chest

154

2.22

6.68

1.1

2.80

2.96

u/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

174

2.08

6.42

1.0

1.1

2.93

2.17

u/ml

—

ILD medications: prednisolone, methylprednisolone, prednisone

187

2.03

6.31

1.1

3.46

2.16

u/ml

—

Spondylosis

2.72

5.97

1.1

—

3.53

—

Symptoms and signs involving the circulatory and respiratory systems

163

2.03

5.93

1.1

2.26

2.96

u/ml

—

General symptoms and signs

177

1.98

5.91

1.1

2.90

1.98

u/ml

—

Anaemias

3.73

5.90

1.1

1.0

—

4.73

—

Codeine or tramadol medication

203

1.94

5.88

1.1

1.45

2.93

u/ml

—

Abnormalities of breathing

162

2.08

5.79

1.1

1.67

2.96

u/ml

—

Soft tissue disorders related to use, overuse and pressure

3.60

5.75

1.1

—

3.02

—

Inflammatory bowel disease treatment related agents

210

1.92

5.73

1.1

3.69

2.09

u/ml

—

Asthma, including avohilmo

215

1.88

5.44

1.2

1.1

2.99

2.43

u/ml

—

Infections, IBD-co-morbidities

10.21

5.18

1.0

—

Other diseases of upper respiratory tract

178

1.90

5.02

1.1

3.12

2.60

u/ml

—

Oral corticosteroids

200

1.87

4.79

1.1

4.30

2.16

u/ml

—

Dislocation, sprain and strain of joints and ligaments at neck level

3.34

4.60

1.0

1.2

—

2.12

—

Diseases of arteries, arterioles and capillaries

102

2.32

4.45

1.1

1.46

2.42

u/ml

—

Neurological diseases

136

1.96

4.44

1.2

1.1

2.80

3.01

u/ml

—

Any mental disorder

169

1.84

4.33

1.1

1.38

3.20

u/ml

—

Autoimmune diseases

180

1.81

4.28

1.1

2.53

2.17

u/ml

—

Triptan medication for migraine, single purchase ok

196

1.87

4.25

1.1

1.12

3.13

u/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

196

1.87

4.25

1.1

1.12

3.13

u/ml

—

Injuries to the neck

2.74

4.17

1.0

1.2

—

2.02

—

Diseases of the skin and subcutaneous tissue

161

1.84

4.15

1.2

1.1

2.56

1.97

u/ml

—

Other diseases of intestines

208

1.75

3.98

1.1

3.78

2.22

u/ml

—

Other specified/unspecified soft tissue disorders

12.03

3.76

1.2

1.0

—

Migraine without aura and triptan purchases

2.69

3.65

1.0

1.2

—

3.04

—

Parasetamol

112

1.95

3.61

1.2

1.1

1.35

3.52

u/ml

—

Symptoms and signs involving the digestive system and abdomen

147

1.81

3.58

1.2

1.1

1.27

2.27

u/ml

—

Used for control exclusion in common control thyroid runs

167

1.75

3.58

1.1

2.53

2.12

u/ml

—

Selective serotonin reuptake inhibitors

158

1.78

3.55

1.1

1.29

3.20

u/ml

—

Persons encountering health services for examination and investigation

2.17

3.53

1.3

1.1

2.76

3.33

u/ml

—

Disorders of continuity of bone

4.08

3.39

1.0

1.2

—

1.12

—

Disturbances of skin sensation

2.39

3.38

1.1

—

1.86

—

Other special examinations and investigations of persons without complaint or reported diagnosis

2.12

3.28

1.3

1.1

3.00

3.33

u/ml

—

Diseases of the eye and adnexa

141

1.78

3.24

1.1

2.45

2.99

u/ml

—

Symptoms and signs involving the skin and subcutaneous tissue

215

1.82

3.21

1.1

—

2.20

—

Migraine without aura

2.44

3.20

1.1

—

1.90

—

Subjective visual disturbances

2.54

3.12

1.1

—

2.06

—

Other reaction to severe stress, and adjustment disorders

133

2.03

3.00

1.1

—

3.21

—

Tinnitus

2.75

2.98

1.1

1.2

—

2.09

—

Abdominal and pelvic pain

147

1.71

2.88

1.2

1.1

1.27

2.27

u/ml

—

Allergic urticaria

4.10

2.88

1.0

1.3

—

2.62

—

Other bursopathies

6.67

2.86

1.3

1.2

—

Other nutritional deficiencies

224

1.72

2.77

1.0

1.1

—

2.64

—

Atrophic disorders of skin

3.08

2.76

1.0

1.3

—

2.17

—

Gastrointestinal diseases

1.89

2.76

1.1

2.26

2.74

u/ml

—

Psoriasis vulgaris

3.00

2.69

1.1

1.3

—

1.20

—

Benign neoplasm: Sigmoid colon

3.34

2.60

1.1

1.2

—

1.18

—

Obesity related asthma

107

2.06

2.56

1.1

—

2.05

—

Disorders of conjunctiva

240

1.61

2.47

1.1

2.88

2.51

u/ml

—

Inflammatory diseases of female pelvic organs

198

1.63

2.39

1.1

3.18

2.49

u/ml

—

Cystitis

179

1.59

2.29

1.0

1.1

2.64

1.98

u/ml

—

Cardiovascular diseases

136

1.66

2.29

1.3

1.1

2.49

3.24

u/ml

—

Endometriosis of ovary

2.44

2.24

1.0

1.1

—

1.65

—

Other and unspecified disorders of vitreous body

2.01

2.22

1.1

—

1.63

—

Bacterial intestinal infections, IBD co-morbidities

2.78

2.13

1.0

1.2

—

1.20

—

COPD differential diagnosis

129

1.63

2.13

1.2

1.1

2.58

2.38

u/ml

—

ILD differential diagnosis

129

1.63

2.13

1.2

1.1

2.58

2.38

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

203

1.56

2.10

1.1

1.97

2.83

u/ml

—

Dyspnoea

213

1.56

2.08

1.1

1.50

2.44

u/ml

—

Any reimbursement code in KELA

119

1.64

2.04

1.2

1.1

2.24

3.13

u/ml

—

Conjunctivitis

237

1.55

2.02

1.1

2.88

2.59

u/ml

—

Noninflammatory disorders of female genital tract

1.75

2.02

1.2

1.1

2.15

2.98

u/ml

—

Other diseases of lip and oral mucosa

125

1.84

2.01

1.2

1.1

—

2.09

—

Intestinal infectious diseases

229

1.47

2.00

1.1

1.39

3.02

u/ml

—

Acute upper respiratory infections

224

1.48

1.95

1.1

1.59

2.96

u/ml

—

Mycoses

250

1.53

1.94

1.0

1.1

1.46

2.85

u/ml

—

Other disorders of eye and adnexa

2.57

1.94

1.0

1.2

—

2.06

—

Diarrhoea and gastroenteritis of presumed infectious origin

232

1.48

1.87

1.1

1.43

3.02

u/ml

—

COPD/asthma/ILD related infections

191

1.47

1.85

1.1

1.61

2.69

u/ml

—

COPD/asthma related infections

191

1.47

1.85

1.1

1.61

2.69

u/ml

—

Caries of enamel

226

1.50

1.85

1.1

2.84

2.60

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

182

1.48

1.81

1.2

1.1

1.40

3.03

u/ml

—

Excluding asthma or asthma-COPD overlap

132

1.56

1.77

1.2

1.1

2.58

2.38

u/ml

—

Other pulmonary diagnosis

132

1.56

1.77

1.2

1.1

2.90

2.38

u/ml

—

2.34

1.77

1.1

—

2.08

—

Diseases of the myoneural junction and muscle

2.92

1.72

1.1

1.2

—

1.14

—

Adverse effects, not elsewhere classified

2.13

1.71

1.0

1.2

—

2.02

—

Allergic conjunctivitis

220

1.55

1.69

1.1

2.88

2.04

u/ml

—

Extrapyramidal and movement disorders

1.95

1.69

1.2

1.1

—

2.04

—

Antihypertensive medication - note that there are other indications

134

1.54

1.67

1.2

1.1

2.72

3.01

u/ml

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.89

1.64

1.1

—

1.98

—

Other bacterial intestinal infections

2.44

1.64

1.0

1.2

—

2.34

—

Enthesopathies of lower limb, excluding foot

2.25

1.63

1.0

1.1

—

2.73

—

Other bacterial intestinal infections

2.14

1.60

1.0

1.2

—

2.34

—

Disorders of vitreous body and globe

124

1.70

1.54

1.0

1.1

—

2.13

—

Psoriasis

1.92

1.54

1.1

1.2

—

2.23

—

Enlarged lymph nodes

2.43

1.53

1.0

1.2

—

2.47

—

Brachial plexus disorders

2.60

1.51

1.0

1.2

—

2.40

—

Unspecified acute lower respiratory infection

0.00

1.51

0.0

1.2

—

2.21

—

Obesity

225

1.50

1.49

1.1

—

2.64

—

Any gastric operation

155

1.46

1.49

1.2

1.1

1.36

3.25

u/ml

—

GASTRO-related operations

155

1.46

1.49

1.2

1.1

1.36

3.25

u/ml

—

Obesity and other hyperalimentation

225

1.50

1.48

1.1

—

2.64

—

Spinal stenosis

1.84

1.48

1.1

—

2.00

—

Other peripheral vertigo

2.73

1.43

1.0

1.3

—

1.14

—

Demyelinating diseases of the central nervous system

2.42

1.39

1.1

1.2

—

2.68

—

Transport accidents

128

1.61

1.38

1.1

—

2.44

—

Other psoriatic arthropathies

2.61

1.36

1.2

—

1.12

—

Arthropathic psoriasis

2.61

1.36

1.2

1.3

—

1.12

—

Other puerperal infections

0.00

1.34

0.0

1.1

—

2.27

—

Disorders of vitreous body

123

1.65

1.34

1.0

1.1

—

2.13

—

Neoplasms

155

1.44

1.33

1.2

1.1

2.37

2.50

u/ml

—

Other disorders of urethra and urinary system

172

1.47

1.32

1.2

1.1

—

1.98

—

Certain infectious and parasitic diseases

185

1.38

1.30

1.1

1.20

2.82

u/ml

—

Psoriatic arthropathies, ICD10

2.50

1.30

1.2

1.3

—

1.12

—

Otalgia

2.78

1.28

1.0

1.3

—

1.02

—

Infective dermatitis

2.78

1.28

1.6

1.2

—

1.08

—

Obesity due to excess calories

169

1.54

1.28

1.0

1.1

—

2.21

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

2.08

1.27

1.1

1.3

—

1.20

—

Other extrapyramidal and movement disorders in other diseases

2.08

1.27

1.3

1.2

—

2.04

—

Cervicobrachial syndrome

2.08

1.27

1.1

—

3.00

—

Other diseases of pleura

1.83

1.25

1.1

1.2

—

1.46

—

Chondropathies

2.00

1.23

1.0

1.2

—

2.06

—

Other disorders of bone

1.91

1.22

1.1

1.2

—

2.10

—

Deforming dorsopathies

1.91

1.22

1.2

1.1

—

2.56

—

Other contact dermatitis

2.63

1.21

1.4

1.2

—

1.22

—

Oedema, not elsewhere classified

1.83

1.19

1.2

1.1

—

2.39

—

Lichen planus, including avohilmo

2.11

1.18

1.1

1.3

—

1.20

—

Persons encountering health services in other circumstances

140

1.56

1.17

1.0

1.1

—

2.70

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

0.00

1.16

0.0

1.2

—

2.74

—

Papulosquamous disorders

110

1.64

1.15

1.1

—

2.16

—

Symptoms and signs involving the nervous and musculoskeletal systems

174

1.49

1.14

1.2

1.1

—

2.25

—

Bleeding

168

0.59

1.13

1.0

1.1

—

1.97

—

Otitis externa

1.85

1.13

1.3

1.2

—

2.06

—

210

1.33

1.13

1.1

1.63

2.54

u/ml

—

Benign neoplasm of breast

2.34

1.12

1.3

1.2

—

2.06

—

Other keratitis

2.34

1.12

1.0

1.3

—

2.40

—

Diseases of the respiratory system

102

1.47

1.11

1.2

1.1

2.34

2.36

u/ml

—

Superficial injury of forearm

2.26

1.10

1.0

1.2

—

1.08

—

Other and unspecified effects of external causes

1.67

1.10

1.1

—

2.02

—

Pacemaker

1.97

1.09

1.0

1.2

—

1.13

—

Benign mammary dysplasia

2.19

1.08

1.1

1.3

—

1.12

—

5-aminosalicylic acid

1.92

1.02

1.0

1.1

—

1.30

—

Dental caries

1.89

1.00

1.1

—

2.57

—

Other female pelvic inflammatory diseases

1.88

1.00

1.0

1.2

—

2.30

—

MS-disease / Multiple Sclerosis

2.18

0.98

1.0

1.2

—

2.68

—

Benign neoplasms

192

1.32

0.97

1.2

1.1

2.48

2.22

u/ml

—

Ventral hernia

1.80

0.96

1.2

—

2.09

—

Blepharochalasis

1.85

0.96

1.2

—

1.15

—

Keratitis

108

1.57

0.96

1.1

—

2.06

—

Hyperkinetic disorders, excluding more controls

1.79

0.96

1.0

1.1

—

3.75

—

Stomatitis and related lesions

1.77

0.94

1.3

1.2

—

2.06

—

Car occupant injured in other and unspecified transport accidents

1.78

0.94

1.1

1.2

—

2.02

—

Obsessive-compulsive disorder

2.07

0.89

1.2

1.1

—

2.96

—

ILD medications: azathioprine

2.07

0.89

1.0

1.1

—

1.08

—

Aneurysms, operations, SAH

2.07

0.89

1.0

1.2

—

1.17

—

Puerperal sepsis

1.91

0.88

1.0

1.2

—

2.24

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2.00

0.87

1.2

1.3

—

2.29

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

206

1.37

0.85

1.0

1.1

2.88

2.04

u/ml

—

Open wound of head

124

1.48

0.83

1.0

1.1

—

2.27

—

Antenatal screening

0.59

0.82

1.4

1.1

—

2.70

—

Urticaria

113

1.50

0.81

1.1

—

2.39

—

Abnormal involuntary movements

1.88

0.81

1.0

1.2

—

2.17

—

Glucosamine medication

1.55

0.80

1.0

1.1

—

1.53

—

Calculus of kidney and ureter

1.72

0.79

1.0

1.2

—

2.11

—

Urolithiasis

1.72

0.79

1.0

1.2

—

2.11

—

Haemangioma, any site

0.00

0.79

0.0

1.3

—

1.12

—

Haemangioma and lymphangioma, any site

0.00

0.78

0.0

1.2

—

1.12

—

Disorders of the thyroid gland

219

1.28

0.78

1.2

1.1

3.38

2.38

u/ml

—

Single delivery by caesarean section

0.59

0.76

1.4

1.1

—

2.51

—

Thyroiditis, ILD-related definition

1.77

0.76

1.0

1.1

—

2.06

—

Restless leg syndrome

1.77

0.76

1.3

1.2

—

2.17

—

Ulcerative colitis, NAS

1.77

0.76

1.3

1.2

—

1.12

—

Stenosis and insufficiency of lacrimal passages

2.08

0.74

1.0

1.3

—

1.14

—

Other disorders of cornea

2.08

0.74

1.0

1.3

—

1.14

—

Assault

1.84

0.73

1.0

1.2

—

2.42

—

Disturbance of activity and attention

1.63

0.73

1.0

1.1

—

2.49

—

Lichen planus

2.00

0.72

1.2

—

1.17

—

IBD patients in KELA-register

1.62

0.71

1.2

1.1

—

1.31

—

Childhood asthma (age<16)

1.68

0.71

1.3

1.1

—

2.93

—

Childhood asthma (age<16), excluding more controls

1.68

0.71

1.3

1.1

—

2.93

—

Other disorders of the genitourinary system

1.92

0.70

1.0

1.3

—

1.17

—

Fracture of lumbar spine and pelvis

1.70

0.69

1.1

—

1.18

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

191

1.27

0.69

1.1

2.94

2.69

u/ml

—

191

1.27

0.69

1.1

2.94

2.69

u/ml

—

Poisoning by drugs, medicaments and biological substances

1.53

0.68

1.0

1.2

—

2.02

—

Other and unspecified mood [affective] disorders

1.85

0.68

1.0

1.2

—

2.72

—

Other specified and unspecified personality disorders

1.85

0.68

1.0

1.3

—

2.42

—

Other disorders of kidney and ureter

1.85

0.68

1.0

1.2

—

1.14

—

Malignant melanoma of skin, including Hilmo

1.85

0.68

1.2

—

1.06

—

Conjunctivitis (acute, non atopic)

1.50

0.68

1.2

—

1.26

—

Inflammatory bowel disease, strict (require KELA)

1.59

0.68

1.2

1.1

—

2.12

—

Other congenital malformations

1.63

0.66

1.1

1.2

—

2.10

—

Postprocedural disorders of nervous system

1.79

0.66

1.0

1.2

—

2.45

—

Pedal cyclist injured in noncollision transport accidents

1.79

0.66

1.0

1.2

—

1.08

—

Injuries to unspecified part of trunk, limb or body region

1.79

0.66

1.0

1.2

—

1.22

—

Other and unspecified nerve root and plexus disorders, also in other diseases

1.59

0.65

1.0

1.1

—

2.30

—

Medicines for HER+ breast cancer

121

0.63

0.64

1.0

1.1

—

2.02

—

Superficial injury of hip and thigh

1.72

0.64

1.0

1.2

—

1.18

—

Chronic periodontitis, complicated

136

1.38

0.63

1.0

1.1

—

2.00

—

Hyperparathyroidism

1.70

0.63

1.0

1.2

—

1.15

—

Phobic anxiety disorders

1.63

0.62

1.1

—

2.44

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.59

0.61

1.1

1.2

—

2.23

—

Other inflammation of eyelid

1.67

0.61

1.6

1.3

—

1.20

—

Benign neoplasm: Rectum

1.67

0.61

1.0

1.2

—

1.18

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

104

1.44

0.61

1.1

—

3.37

—

Paralytic ileus and intestinal obstruction

1.60

0.61

1.0

1.1

—

2.04

—

Leiomyoma of uterus

142

1.28

0.60

1.1

3.17

2.13

u/ml

—

Disorders of sclera, cornea, iris and ciliary body

165

1.33

0.60

1.0

1.1

—

2.16

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

0.59

0.0

1.2

—

1.08

—

Disorders of gallbladder, biliary tract and pancreas

204

1.24

0.59

1.1

1.60

2.44

u/ml

—

Other symptoms and signs involving the nervous and musculoskeletal systems

140

1.36

0.58

1.3

1.1

—

2.32

—

Obesity, other/unspecified

132

1.36

0.56

1.1

—

2.20

—

Coeliac disease

1.67

0.56

1.2

—

1.19

—

Crohn disease

1.62

0.55

1.3

1.2

—

1.11

—

Pneumonias (Asthma/COPD co-morbidities)

238

1.21

0.55

1.1

2.94

1.86

u/ml

—

Hyperkinetic disorders

1.52

0.54

1.0

1.1

—

2.49

—

Acute pharyngitis

1.51

0.54

1.0

1.2

—

2.25

—

Disorders of parathyroid gland

1.56

0.53

1.0

1.3

—

1.15

—

Pneumonia, organism unspecified

212

1.22

0.52

1.1

1.96

1.81

u/ml

—

Other metabolic disorders

1.50

0.51

1.0

1.2

—

2.34

—

Intestinal stricture

1.38

0.50

1.0

1.2

—

2.04

—

Recurrent aphthous stomatitis , including avohilmo

1.46

0.50

1.5

1.2

—

2.15

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

233

1.20

0.49

1.1

1.96

2.21

u/ml

—

Other and unspecified anaemias

1.43

0.49

1.0

1.2

—

2.04

—

Maternal care for known or suspected abnormality of pelvic organs

1.35

0.48

1.2

1.1

—

1.01

—

Emotionally unstable personality disorder

1.52

0.48

1.0

1.2

—

2.17

—

Tonsillectomy and adenotomy

169

1.24

0.47

1.1

—

2.68

—

All pneumoniae

242

1.19

0.47

1.1

2.94

2.45

u/ml

—

Leisure time condition

1.46

0.46

1.0

1.2

—

2.06

—

Malignant neoplasm of breast, HER-positive

0.68

0.46

1.0

1.1

—

2.22

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.67

0.46

1.0

1.1

—

2.22

—

Other medical care

106

0.68

0.46

1.1

—

2.23

—

Childhood allergy (age < 16)

1.47

0.46

1.2

1.1

—

2.71

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.43

0.46

1.3

1.2

—

2.10

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.41

0.45

1.1

1.2

—

2.21

—

Suicide or other Intentional self-harm

1.40

0.44

1.1

1.2

—

2.08

—

Certain infectious and parasitic diseases

118

1.23

0.43

1.2

1.1

1.35

3.96

u/ml

—

Appendectomy

220

1.22

0.42

1.1

—

2.25

—

Chronic periodontitis, including avohilmo

209

1.19

0.41

1.1

—

2.20

—

Inflammatory disease of cervix uteri

0.00

0.41

0.0

1.3

—

1.14

—

Other anaemias

1.37

0.41

1.0

1.2

—

2.04

—

Use of rivastigmine

0.00

0.40

0.0

1.3

—

1.14

—

Periodontitis

209

1.18

0.40

1.1

—

2.20

—

Injury of muscle and tendon at lower leg level

1.47

0.40

1.0

1.2

—

1.33

—

Benign neoplasm: Rectum, anus and anal canal

1.47

0.40

1.0

1.2

—

1.17

—

Other and unspecified urticaria

1.31

0.39

1.3

1.2

—

2.16

—

Inflammatory bowel disease

1.34

0.39

1.2

1.1

—

2.07

—

Injury of muscle and tendon at shoulder and upper arm level

1.36

0.38

1.0

1.2

—

2.34

—

Noninfectious colitis NAS

1.39

0.38

1.0

1.2

—

1.19

—

Seborrhoeic keratosis

1.39

0.38

1.0

1.4

—

1.17

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1.35

0.37

1.0

1.2

—

2.34

—

Superficial injury of wrist and hand

1.30

0.37

1.0

1.1

—

2.02

—

Ulcerative colitis

1.30

0.37

1.2

1.1

—

1.31

—

COPD, hospital admissions

0.65

0.36

1.0

1.2

—

1.47

—

COPD, early/later onset

0.64

0.36

1.0

1.2

—

1.47

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.36

0.34

1.3

1.2

—

2.10

—

Other heart diseases, wide

212

1.15

0.34

1.2

1.1

3.12

1.97

u/ml

—

Diverticular disease of intestine

115

1.22

0.34

1.0

1.1

—

1.85

—

Exclusions for E4_PCOS_CONSORTIUM

200

1.16

0.33

1.1

3.20

1.79

u/ml

—

LSIL lesion of the cervix uteri

1.30

0.33

1.2

—

2.25

—

1.28

0.32

1.2

1.1

—

2.31

—

Ulcerative colitis (strict definition, require KELA)

1.28

0.32

1.3

1.2

—

2.10

—

Cholelithiasis, broad definition with cholecystitis

197

1.16

0.32

1.1

1.60

2.44

u/ml

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.36

0.31

1.1

1.2

—

2.15

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

146

1.23

0.31

1.1

—

2.76

—

Covid-19 confirmed case

0.73

0.30

1.1

—

1.86

—

Substance use, excluding alcohol

1.30

0.30

1.0

1.2

—

2.10

—

Single delivery by forceps and vacuum extractor

0.74

0.30

1.3

1.1

—

3.03

—

Primary gonarthrosis, bilateral

103

1.25

0.29

1.2

1.1

—

1.77

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.23

0.29

1.0

1.2

—

2.12

—

Obstructed labour due to malposition and malpresentation of fetus

104

1.26

0.28

1.1

—

2.10

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

121

1.24

0.28

1.1

—

2.27

—

Malignant neoplasm of skin

0.77

0.28

1.1

—

1.83

—

Other disorders of eyelid

1.26

0.28

1.2

1.1

—

1.31

—

Fall on and from stairs and steps

1.25

0.27

1.0

1.2

—

1.95

—

Pedal cyclist injured in transport accident

1.21

0.26

1.0

1.2

—

2.08

—

Type of accident

1.26

0.24

1.0

1.2

—

2.25

—

Substance abuse, excluding more controls

121

1.20

0.24

1.1

—

3.20

—

Cutaneous abscess, furuncle and carbuncle

0.74

0.24

1.0

1.2

—

2.08

—

Aplastic and other anaemias

1.24

0.23

1.0

1.1

—

1.96

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

1.32

0.23

1.0

1.2

—

2.24

—

Hernia of abdominal wall

106

1.23

0.23

1.2

1.1

—

2.11

—

Deep bite

1.29

0.23

1.0

1.2

—

1.02

—

Influenza and pneumonia

247

1.11

0.22

1.1

2.94

2.45

u/ml

—

Allergic contact dermatitis

1.25

0.22

1.2

—

2.30

—

Poisoning by medicine

1.27

0.22

1.0

1.2

—

2.02

—

157

0.84

0.22

1.1

—

1.86

—

Congenital malformations and deformations of the musculoskeletal system

1.21

0.22

1.0

1.2

—

2.21

—

Acute appendicitis, no complications

190

1.15

0.22

1.0

1.1

—

2.21

—

Complications of labour and delivery

174

1.12

0.21

1.1

2.73

2.82

u/ml

—

Sequelae with surgical and medical care as external cause

1.19

0.21

1.0

1.2

—

1.20

—

Other salmonella infections

0.00

0.21

0.0

1.3

—

Struck by thrown, projected or falling objec

0.00

0.21

0.0

1.3

—

Hydrocele

0.00

0.21

0.0

1.2

—

Congenital malformations of the circulatory system

1.18

0.21

1.2

—

2.21

—

Duodenal ulcer

0.00

0.21

0.0

1.2

—

Caries of dentine

1.27

0.20

1.0

1.1

—

2.57

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

0.77

0.20

1.0

1.2

—

1.74

—

Fracture of skull and facial bones

1.25

0.20

1.0

1.3

—

2.31

—

Combinations of oral blood glucose lowering drugs

1.25

0.20

1.0

1.2

—

1.43

—

Superficial injury of head

1.15

0.19

1.0

1.2

—

2.26

—

Cellulitis

1.21

0.18

1.1

1.2

—

2.12

—

Skin changes due to chronic exposure to nonionizing radiation

1.20

0.18

1.1

—

1.36

—

1.13

0.17

1.1

—

1.36

—

Other chronic obstructive pulmonary disease

0.74

0.17

1.0

1.1

—

1.44

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.11

0.17

1.0

1.2

—

2.06

—

Hyperlipidaemia, other/unspecified

0.75

0.17

1.0

1.2

—

1.52

—

Insomnia

247

1.09

0.16

1.1

—

2.64

—

Care involving use of rehabilitation procedures

188

0.88

0.16

1.1

—

2.33

—

Tooth eruption problems

1.11

0.16

1.3

1.1

—

2.83

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

119

1.16

0.15

1.1

—

2.16

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.79

0.15

1.0

1.2

—

2.20

—

Benign paroxysmal vertigo

1.15

0.15

1.0

1.2

—

2.14

—

Acute appendicitis

229

1.10

0.15

1.0

1.1

—

2.20

—

Cardiovascular diseases (excluding rheumatic etc)

169

1.09

0.14

1.2

1.1

1.33

3.46

u/ml

—

Medical treatment for female infertility

0.84

0.13

1.0

1.1

—

2.28

—

Coxarthrosis, primary, with hip surgery

1.17

0.11

1.0

1.1

—

1.51

—

Fever of other and unknown origin

136

1.11

0.11

1.1

—

1.93

—

Infections of the skin and subcutaneous tissue

186

0.90

0.11

1.1

—

2.56

—

Alcohol use disorder, ICD-based

1.15

0.10

1.0

1.2

—

1.99

—

Fracture of shoulder and upper arm

1.14

0.10

1.1

1.2

—

2.16

—

Implicit viral Sepsis

1.14

0.10

1.0

1.2

—

1.10

—

Polyuria

1.14

0.10

1.0

1.2

—

1.18

—

Myopia

1.11

0.09

1.0

1.2

—

2.12

—

Viral Sepsis

1.11

0.09

1.0

1.2

—

1.98

—

Primary coxarthrosis, bilateral

1.06

0.09

1.2

1.1

—

1.36

—

COPD, hospital admissions 1, only main diagnosis

1.04

0.09

1.0

1.1

—

1.10

—

Benign neoplasm of ovary

1.04

0.09

1.0

1.2

—

1.38

—

Non-allergic asthma (mode), excluding more controls

1.03

0.09

1.2

1.1

—

1.28

—

Actinic keratosis

1.09

0.09

1.2

1.1

—

1.37

—

Pediculosis, acariasis and other infestations

1.05

0.08

1.7

1.2

—

2.26

—

Fracture of rib(s), sternum and thoracic spine

1.03

0.08

1.0

1.2

—

1.34

—

Injuries to the thorax

107

1.12

0.08

1.1

—

1.96

—

Obstructed labour due to maternal pelvic abnormality

0.83

0.08

1.0

1.1

—

1.43

—

Pulmonary heart disease

0.83

0.08

1.0

1.2

—

1.16

—

Pulmonary embolism

0.83

0.08

1.0

1.2

—

1.16

—

Effects of foreign body entering through natural orifice

0.77

0.08

1.0

1.2

—

2.12

—

Pulmonary heart disease, diseases of pulmonary circulation

0.77

0.08

1.0

1.2

—

1.34

—

Speech therapy

1.06

0.08

1.1

1.2

—

2.06

—

Mycoses

1.06

0.08

1.3

1.2

—

2.06

—

Malignant neoplasm of digestive organs

0.83

0.07

1.0

1.2

—

1.65

—

COPD

0.82

0.07

1.0

1.1

—

1.59

—

Ectopic pregnancy

1.07

0.07

1.1

—

2.20

—

Benign lipomatous neoplasm

1.07

0.07

1.4

1.1

—

2.19

—

Herpesviral [herpes simplex] infections

0.89

0.06

1.0

1.1

—

2.05

—

Nonsuppurative otitis media

0.84

0.06

1.1

—

2.74

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.85

0.06

1.3

1.1

—

2.39

—

Glucagon-like peptide-1 (GLP-1) analogues

0.85

0.06

1.3

1.1

—

2.39

—

Other chronic obstructive pulmonary disease, including avohilmo

0.90

0.06

1.1

1.2

—

1.60

—

Bacterial pneumoniae

0.89

0.06

1.0

1.2

—

2.23

—

DVT of lower extremities and pulmonary embolism

100

0.90

0.06

1.0

1.1

—

2.02

—

Kela-code for severe mental illness

121

0.91

0.06

1.0

1.1

—

1.91

—

Presence of other functional implants

0.91

0.05

1.2

1.1

—

2.46

—

Unspecified mental disorder

141

0.92

0.05

1.0

1.1

—

2.46

—

Alcohol use disorder, Swedish definition

129

0.92

0.05

1.0

1.1

—

1.86

—

Mental and behavioural disorders due to psychoactive substance use

168

0.94

0.05

1.1

—

1.82

—

Preterm labour and delivery

110

1.09

0.05

1.1

—

2.28

—

Appendicitis, broad definition

234

1.04

0.04

1.0

1.1

—

2.20

—

Diseases of appendix

235

1.04

0.02

1.0

1.1

—

2.20

—

Maternal care for other conditions predominantly related to pregnancy

110

1.07

0.02

1.0

1.1

—

1.78

—

Mental and behavioural disorders due to alcohol

131

0.95

0.01

1.1

—

1.92

—

141

0.96

0.00

1.1

—

1.86

—

Gonarthrosis, primary, with knee surgery

108

0.96

0.00

1.0

1.1

—

1.77

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.02

0.00

1.2

—

1.60

—

Substance abuse

163

0.98

0.00

1.1

—

1.82

—

Inguinal hernia

0.98

0.00

1.0

1.2

—

1.95

—

Complications predominantly related to the puerperium

118

1.02

0.00

1.0

1.1

—

2.32

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

105

1.05

0.00

1.1

—

2.07

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

107

1.02

0.00

1.0

1.1

—

1.99

—

Communicating hydrocephalus

0.00

0.0

1.4

—

Spermatocele

0.00

0.0

1.4

—

Pterygium

0.00

0.0

1.4

—

Benign neoplasm: Brain, supratentorial

0.00

0.0

1.3

—

Other disorders involving the immune mechanism, not elsewhere classified

0.00

0.0

1.3

—

Injury of muscle and tendon at forearm level

0.00

-0.00

0.0

1.4

—

Injury of nerves at forearm level

0.00

-0.00

0.0

1.4

—

Injury of muscle and tendon at ankle and foot level

0.00

-0.00

0.0

1.3

—

Acute appendicitis, with complications

0.94

-0.00

1.0

1.2

—

2.23

—

Toxic effect of alcohol

0.00

-0.00

0.0

1.4

—

Toxic effect of other and unspecified substances

0.00

-0.00

0.0

1.4

—

Other abnormal findings in urine

0.00

-0.00

0.0

1.4

—

Haemorrhage from respiratory passages

0.90

-0.00

1.0

1.1

—

2.48

—

Isolated proteinuria

0.00

-0.00

0.0

1.4

—

Unspecified jaundice

0.00

-0.00

0.0

1.0

—

Nausea and vomiting

0.93

-0.00

1.0

1.1

—

2.60

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

1.0

—

Somnolence

0.00

-0.00

0.0

1.4

—

L02BX Other hormone antagonists and related agents

0.00

-0.00

0.0

1.4

—

Burn and corrosion of head and neck

0.00

-0.00

0.0

1.4

—

L02BA Anti-estrogens

0.94

-0.00

1.0

1.2

—

2.04

—

Patent foramen ovale

0.00

-0.00

0.0

1.4

—

Laparoscopic left hemicolectomy

0.00

-0.00

0.0

1.6

—

Ovarian hyperstimulation (induction)

0.00

-0.00

0.0

1.0

—

Habitual aborter

0.00

-0.00

0.0

1.0

—

Polyarteritis nodosa and related conditions

0.00

-0.00

0.0

1.4

—

Acute posthaemorrhagic anaemia

0.00

-0.00

0.0

1.5

—

Complications associated with artificial fertilization

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

1.02

-0.00

1.2

—

2.16

—

Idiopathic urticaria

0.00

-0.00

0.0

1.3

—

Other specified/unspecified disorders of bone/cartilage

0.00

-0.00

0.0

1.4

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

-0.00

0.0

1.4

—

Overjet

0.00

-0.00

0.0

1.0

—

Bacterial pneumonia, not elsewhere classified

0.92

-0.00

1.0

1.2

—

2.23

—

Perichondritis of external ear

0.00

-0.00

0.0

1.4

—

Other intracranial haemorrhages

0.00

-0.00

0.0

1.4

—

Chronic mastoiditis

0.00

-0.00

0.0

1.4

—

Optic atrophy

0.00

-0.00

0.0

1.4

—

Pericarditis

0.00

-0.00

0.0

1.3

—

Endocarditis

0.00

-0.00

0.0

1.4

—

Iridocyclitis in diseases classified elsewhere

0.00

-0.00

0.0

1.4

—

Habit and impulse disorders

0.00

-0.00

0.0

1.3

—

Monoplegia

0.00

-0.00

0.0

1.6

—

Other disorders of binocular vision

0.00

-0.00

0.0

1.4

—

Vitamin D deficiency

0.00

-0.00

0.0

1.3

—

Malnutrition

0.00

-0.00

0.0

1.3

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

0.00

-0.00

0.0

1.3

—

COPD (mode)

0.96

-0.00

1.0

1.1

—

1.34

—

Benign neoplasm: Duodenum

0.00

-0.00

0.0

1.6

—

Parapsoriasis

0.00

-0.00

0.0

1.4

—

Basal cell carcinoma

0.99

-0.00

1.2

—

1.60

—

Impotence

0.00

-0.00

0.0

1.4

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

1.0

—

Syphilis

0.00

-0.00

0.0

1.5

—

Tularaemia

0.00

-0.00

0.0

1.4

—

Mumps

0.00

-0.00

0.0

1.4

—

Alcohol dependence

0.85

-0.00

1.0

1.2

—

1.34

—

Syphilis

0.00

-0.00

0.0

1.5

—

Tularaemia

0.00

-0.00

0.0

1.4

—

Erectile dysfunction

0.00

-0.00

0.0

1.3

—

Cleft palate

0.00

-0.00

0.0

1.4

—

Iridocyclitis

0.86

-0.00

1.2

—

2.17

—

Basal cell carcinoma, including avohilmo

0.94

-0.00

1.2

—

1.60

—

Viral pneumonia (known virus, not influenza)

0.00

-0.00

0.0

1.4

—

Alcohol-induced acute pancreatitis

0.00

-0.00

0.0

1.5

—

IgA nephropathy (IgA glomerulonephritis)

0.00

-0.00

0.0

1.4

—

Abdominal aortic aneurysm (AAA)

0.00

-0.00

0.0

1.3

—

Corneal degeneration

0.00

-0.00

0.0

1.4

—

Diseases of spleen

0.00

-0.00

0.0

1.4

—

Disorders of refraction and accommodation

0.91

-0.00

1.0

1.1

—

2.02

—

Scabies

0.96

-0.00

1.8

1.1

—

2.42

—

Other and specified injuries of hip and thigh

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Other/unspecified site

0.00

-0.00

0.0

1.5

—

Non-allergic asthma (mode)

1.01

-0.00

1.2

1.1

—

1.28

—

Sequelae of external causes of morbidity and mortality

0.85

-0.00

1.0

1.2

—

1.95

—

Other diseases of pericardium

0.00

-0.00

0.0

1.3

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

-0.00

0.0

1.3

—

Biological medicines for asthma

0.00

-0.00

0.0

1.4

—

Other and unspecified hydrocephalus

0.00

-0.00

0.0

1.4

—

Right bundle-branch block

0.00

-0.00

0.0

1.3

—

Male infertility

0.00

-0.00

0.0

1.3

—

Ankle and foot

0.00

-0.00

0.0

1.4

—

Alcohol abuse counselling and surveillance

0.00

-0.00

0.0

1.3

—

Other fall from one level to another

0.92

-0.00

1.0

1.2

—

2.06

—

Exposure to other and unspecified man-made environmental factors

0.00

-0.00

0.0

1.4

—

Assault by unspecified means

0.00

-0.00

0.0

1.3

—

Superficial injury of lower leg

1.01

-0.00

1.4

1.2

—

2.02

—

Open wound of thorax

0.00

-0.00

0.0

1.4

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Smooth muscle Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS